glp-1 therapy Nutritional priorities to support for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society GLP-1 Therapy Part 1: Setting
Description
Sulfur burps affect anywhere from 2% to 7% of people taking GLP-1 receptor agonists like semaglutide , tirzepatide , and liraglutide, according to clinical trial data filed with the FDA
The result: you stay satisfied longer, eat less, and keep blood sugar stable
That glucose-dependent mechanism is the key distinction
A major challenge in clinical translation is the limited permeability of GLP-1RAs across the blood-brain barrier (BBB)
